欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0318/001
药品名称
StructoKabiven
活性成分
alanine 14.0 g
arginine 12.0 g
calcium chloride 0.56 g
glucose monohydrate 462.0 g
glycine 11.0 g
histidine 3.0 g
isoleucine 5.0 g
leucine 7.4 g
lysine 6.6 g
magnesium sulphate 1.2 g
methionine 4.3 g
phenylalanine 5.1 g
potassium chloride 4.48 g
proline 11.2 g
serine 6.5 g
sodium acetate 3.4 g
sodium glycerophosphate 4.18 g
taurine 1.0 g
threonine 4.4 g
triglyceride, purified structured 200.0 g
tryptophan 2.0 g
tyrosine 0.4 g
valine 6.2 g
zinc sulphate 0.0129 g
剂型
Emulsion for infusion
上市许可持有人
Fresenius Kabi AB Uppsala Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
许可日期
2003/06/12
最近更新日期
2022/05/19
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Article 4.8 (a) (ii)
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0318_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0318_001_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase